Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Ellen van der Plas

High Impact

Associate Professor

Also affiliated: Leiden University (2008); California Institute of Technology (2011); University of Iowa (2008–2024); Arkansas Children's Hospital (2023–2026); Harvard University (2011); University of Antwerp (2018); University of Toronto (2016); University of Washington (2011); Commissariat à l'Énergie Atomique et aux Énergies Alternatives (2009–2011); University of Arkansas Medical Center (2024); Glasgow Royal Infirmary (2022); Hospital for Sick Children (2013–2017); University of Iowa Hospitals and Clinics (2010–2022); Massachusetts General Hospital (2011); CEA Cadarache (2009–2011); Arkansas Children's Nutrition Center (2025); Queen Elizabeth University Hospital (2020); Instituto de Investigaciones Psicológicas (2008); Flemish Institute for Technological Research (2016–2018); University of Glasgow (2021)

Faculty Researcher

23 h-index 92 pubs 1,751 cited

  • Humans
  • Male
  • Child
  • Female
  • Adolescent
  • Brain
  • Adult
  • Magnetic Resonance Imaging
  • Young Adult
  • Cancer Survivors
  • Renal Insufficiency, Chronic
  • Huntington Disease
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Myotonic Dystrophy
  • Survivors

Biography and Research Information

OverviewAI-generated summary

Ellen van der Plas investigates neurological and cognitive outcomes across various patient populations. Her research group's work includes studies on cognitive impairment in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy, exploring brain imaging correlates of these impairments. She also examines the relationship between neurofilament light-chain protein, brain structure, and chronic kidney disease.

Further research by van der Plas focuses on adult-onset myotonic dystrophy type 1, characterizing its core brain symptoms, including cognitive deficits, apathy, and hypersomnolence. Her work also extends to Huntington's disease, investigating neurofilament light protein as a potential blood biomarker for the pediatric form and analyzing longitudinal clinical and biological characteristics of juvenile-onset Huntington's disease. Additionally, she has studied age-related cognitive changes in carriers of mutant huntingtin.

Van der Plas holds an h-index of 23 with 1,734 total citations across 92 publications. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Timothy R. Koscik, with whom she shares 13 publications.

Metrics

  • h-index: 23
  • Publications: 92
  • Citations: 1,751

Selected Publications

  • Long-Term Brain White Matter Outcomes Following Neonatal Acute Kidney Injury (2026)
    medRxiv DOI OpenAlex
  • Feasibility of Non-Sedated Multispectral Neuroimaging in Newly Diagnosed Children with Leukemia (2026)
    medRxiv DOI OpenAlex
  • A supervised STreNgth & Outpatient Exercise Regimen in pediatric patients with Acute Lymphoblastic Leukemia (STRONGER ALL) (2026)
    The American Journal of the Medical Sciences DOI OpenAlex
  • Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
    Blood DOI OpenAlex
  • Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta‐Analysis (2025)
    Cancer Medicine DOI OpenAlex
  • Central Nervous System Iron Content in Pediatric CKD (2025)
    Kidney International Reports DOI OpenAlex
  • Diabetes mellitus and neurocognition: A report from the Childhood Cancer Survivor Study (2025)
    Cancer 1 citation DOI OpenAlex
  • Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
    JAMA Network Open 1 citation DOI OpenAlex
  • An Activation Likelihood Estimation Meta-Analysis of Voxel-Based Morphometry Studies of Chemotherapy-Related Brain Volume Changes in Breast Cancer (2025)
    Cancers 1 citation DOI OpenAlex
  • A Double-Blind, Randomized, Sham-Controlled Clinical Trial of Cerebellar Intermittent Theta Burst Stimulation for Bipolar Disorder: Safety, Tolerability, Mood and Cognitive Effects (2025)
    Biological Psychiatry DOI OpenAlex
  • 130 A supervised strength and outpatient exercise regimen in pediatric patients with acute lymphoblastic leukemia (STRONGER ALL) (2025)
    Journal of Clinical and Translational Science DOI OpenAlex
  • Age-Related Changes in Brain Structure in Pediatric Chronic Kidney Disease (2025)
    JAMA Network Open 6 citations DOI OpenAlex
  • A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects (2024)
    Transcranial magnetic stimulation . 2 citations DOI OpenAlex
  • Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia (2024)
    Translational Pediatrics 2 citations DOI OpenAlex
  • Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (2024)
    Cancer 10 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

82 Collaborators 28 Institutions 3 Countries

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics